Article
Inactivation of intergenic enhancers by EBNA3A initiates and maintains polycomb signatures across a chromatin domain encoding CXCL10 and CXCL9.
PLoS pathogens - 1 Sept 2013
Harth-Hertle Marie L, Scholz Barbara A, Erhard Florian, Glaser Laura V, Dölken Lars, Zimmer Ralf, Kempkes Bettina
Abstract excerpt
Epstein-Barr virus (EBV) causes a persistent infection in human B cells by establishing specific transcription programs to control B cell activation and differentiation. Transcriptional reprogramming of EBV infected B cells is predominantly driven by the action of EBV nuclear antigens, among them the transcriptional repressor EBNA3A. By comparing gene expression profiles of wt and EBNA3A negative EBV infected B...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
